Expression and Prognostic Significance of a Panel of Tissue Hypoxia Markers in Head-and-Neck Squamous Cell Carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 1, 2007, Pages 167-175

  Le, Quynh Thu ^a   Kong, Christina ^b   Lavori, Phillip W ^a   O'Byrne, Ken ^c   Erler, Janine T ^a   Huang, Xin ^a   Chen, Yijun ^a   Cao, Hongbin ^a   Tibshirani, Robert ^a   Denko, Nic ^a   Giaccia, Amato J ^a   Koong, Albert C ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

Author keywords

Head and neck cancer; Hypoxia; Marker panel; Prognosis

Indexed keywords

HEAD-AND-NECK CANCER; HYPOXIA; MARKER PANELS; PROGNOSIS;

CELLS; ENZYME ACTIVITY; GROWTH KINETICS; HISTOLOGY; IMMUNOLOGY; TISSUE;

BIOMARKERS;

CARBONATE DEHYDRATASE IX; CONNECTIVE TISSUE GROWTH FACTOR; DIHYDROFOLATE REDUCTASE; EPHRIN A1; GALECTIN 1; HEMOGLOBIN; HYPOXIA INDUCIBLE GENE 2 PROTEIN; I KAPPA B KINASE; OSTEOPONTIN; PROTEIN; PROTEIN BNIP3; PROTEIN LYSINE 6 OXIDASE; UNCLASSIFIED DRUG;

ADULT; AGE; ANALYSIS OF VARIANCE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FISHER EXACT TEST; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; HYPOXIA; LOG RANK TEST; MALE; MULTIVARIATE ANALYSIS; OXYGEN TENSION; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; UNIVARIATE ANALYSIS;

ANALYSIS OF VARIANCE; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; DISEASE PROGRESSION; EPHRIN-A1; FEMALE; GALECTIN 1; HEAD AND NECK NEOPLASMS; HUMANS; I-KAPPA B KINASE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; OSTEOPONTIN; OXYGEN; PARTIAL PRESSURE; PROGNOSIS; PROTEIN-LYSINE 6-OXIDASE; PROTO-ONCOGENE PROTEINS; TETRAHYDROFOLATE DEHYDROGENASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 34547842084     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.01.071     Document Type: Article

References (45)

1. Brizel D.M., Sibley G.S., Prosnitz L.R., et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38 (1997) 285-289
2. Adam M.F., Gabalski E.C., Bloch D.A., et al. Tissue oxygen distribution in head and neck cancer patients. Head Neck 21 (1999) 146-153
3. Nordsmark M., Overgaard M., and Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 41 (1996) 31-39
4. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
5. Nordsmark M., Bentzen S.M., Rudat V., et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77 (2005) 18-24
6. Le Q.T., and Giaccia A.J. Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Clin Cancer Res 9 (2003) 4287-4295
7. Betensky R.A., Louis D.N., and Cairncross J.G. Influence of unrecognized molecular heterogeneity on randomized clinical trials. J Clin Oncol 20 (2002) 2495-2499
8. Hill R.P. Targeted treatment: Insights from studies of osteopontin and hypoxia. Lancet Oncol 6 (2005) 733-734
9. Evans S.M., and Koch C.J. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195 (2003) 1-16
10. Brown J.M., and Le Q.T. Tumor hypoxia is important in radiotherapy, but how should we measure it?. Int J Radiat Oncol Biol Phys 54 (2002) 1299-1301
11. Raleigh J.A., Calkins-Adams D.P., Rinker L.H., et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. Cancer Res 58 (1998) 3765-3768
12. Evans S.M., Hahn S., Pook D.R., et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res 60 (2000) 2018-2024
13. Bussink J KJ, van der Kogel AJ. Tumor hypoxia at the micro-regional level: Clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 2003;67:3-15.
14. Varghese A.J., Gulyas S., and Mohindra J.K. Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. Cancer Res 36 (1976) 3761-3765
15. Rischin D., Hicks R.J., Fisher R., et al. Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: A substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24 (2006) 2098-2104
16. Koukourakis M.I., Bentzen S.M., Giatromanolaki A., et al. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. J Clin Oncol 24 (2006) 727-735
17. Vordermark D., and Brown J.M. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?. Strahlenther Onkol 179 (2003) 801-811
18. Beasley N.J., Leek R., Alam M., et al. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: Relationship to tumor biology and treatment outcome in surgically resected patients. Cancer Res 62 (2002) 2493-2497
19. Stroka D.M., Burkhardt T., Desbaillets I., et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 15 (2001) 2445-2453
20. Zundel W., Schindler C., Haas-Kogan D., et al. Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev 14 (2000) 391-396
21. Zelzer E., Levy Y., Kahana C., et al. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT. EMBO J 17 (1998) 5085-5094
22. Zhong H., Chiles K., Feldser D., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: Implications for tumor angiogenesis and therapeutics. Cancer Res 60 (2000) 1541-1545
23. Denko N.C., Fontana L.A., Hudson K.M., et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 22 (2003) 5907-5914
24. Chen Y., Shi G., Xia W., et al. Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Cancer Res 64 (2004) 7302-7310
25. Le Q.T., Shi G., Cao H., et al. Galectin-1: A link between tumor hypoxia and tumor immune privilege. J Clin Oncol 23 (2005) 8932-8941
26. Erler J.T., Bennewith K.L., Nicolau M., et al. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440 (2006) 1222-1226
27. Liu C.L., Prapong W., Natkunam Y., et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 161 (2002) 1557-1565
28. Swinson D.E., Jones J.L., Richardson D., et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21 (2003) 473-482
29. Papandreou I., Krishna C., Kaper F., et al. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res 65 (2005) 3171-3178
30. Dornhofer N., Spong S., Bennewith K., et al. Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Cancer Res 66 (2006) 5816-5827
31. Sobin L.H., Hermanek P., and Hutter R.V. TNM classification of malignant tumors. A comparison between the new (1987) and the old editions. Cancer 61 (1988) 2310-2314
32. Terris D.J., and Dunphy E.P. Oxygen tension measurements of head and neck cancers. Arch Otolaryngol Head Neck Surg 120 (1994) 283-287
33. Holzman L.B., Marks R.M., and Dixit V.M. A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein. Mol Cell Biol 10 (1990) 5830-5838
34. McBride J.L., and Ruiz J.C. Ephrin-A1 is expressed at sites of vascular development in the mouse. Mech Dev 77 (1998) 201-204
35. Myers C., Charboneau A., and Boudreau N. Homeobox B3 promotes capillary morphogenesis and angiogenesis. J Cell Biol 148 (2000) 343-351
36. Pandey A., Shao H., Marks R.M., et al. Role of B61, the ligand for the Eck receptor tyrosine kinase, in TNF-alpha-induced angiogenesis. Science 268 (1995) 567-569
37. Ogawa K., Pasqualini R., Lindberg R.A., et al. The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19 (2000) 6043-6052
38. Cheng N., Brantley D.M., and Chen J. The ephrins and Eph receptors in angiogenesis. Cytokine Growth Factor Rev 13 (2002) 75-85
39. Vihanto M.M., Plock J., Erni D., et al. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J 19 (2005) 1689-1691
40. Raza S.M., Fuller G.N., Rhee C.H., et al. Identification of necrosis-associated genes in glioblastoma by cDNA microarray analysis. Clin Cancer Res 10 (2004) 212-221
41. van't Veer L.J., Dai H., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (2002) 530-536
42. van de Vijver M.J., He Y.D., van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
43. Alizadeh A.A., Eisen M.B., Davis R.E., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. [see comments]. Nature 403 (2000) 503-511
44. Rosenwald A., Wright G., Chan W.C., et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 1937-1947
45. Chi J.T., Wang Z., Nuyten D.S., et al. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 3 (2006) e47